DARA Biosciences (DARA)

Add to Watchlists
Create an Alert
2.48 -0.02  -0.80% NASDAQ Apr 16, 8:00PM BATS Real time Currency in USD
View Full Chart
DARA Price Chart
View All Events

DARA Events

Date Type Description
Feb 10 Splits Ratio: 3602879701896397:18014398509481984
Feb 05 Misc SGM Event for Dara Biosciences Inc
Nov 14 Misc Third Quarter 2013 Financial Results Conference Call
Nov 14 Earnings DARA Biosciences to Announce Third Quarter 2013 Financial Results and Corporate Business Update on November 14, 2013. Estimate: -0.10.
Aug 14 Earnings DARA Reports Second Quarter 2013 Financial Results and Operational Overview. Estimate: -0.10.
May 16 Misc DARA Reports First Quarter 2013 Financial Results and Operational Highlights
May 15 Earnings DARA Reports First Quarter 2013 Financial Results and Operational Highlights. Estimate: -0.50.
May 10 Misc AGM Event for Dara Biosciences Inc
View All Performance Charts

DARA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). DARA Biosciences is down 33.95% over the last year vs S&P 500 Total Return up 22.52%, Biodel down 15.19%, and Alcobra up N/A.

Get Quote for

Portfolio Strategies Featuring DARA

Did DARA Biosciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

DARA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

DARA Biosciences, Inc., is a specialty pharmaceutical company focused on the commercialization of oncology treatment and supportive care pharmaceutical products.

Recent Quotes

Symbol Price Chg Chg % Market Cap
DARA 2.48 -0.02 -0.80% 15.41M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.